ArticleCommunications biology2025

Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end.

Jeannette Nilsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.